Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
14.40
+0.35 (2.49%)
Nov 20, 2024, 4:00 PM EST - Market closed
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $774.85 million as of November 21, 2024. Its market cap has decreased by -60.36% in one year.
Market Cap
774.85M
Enterprise Value
267.08M
1-Year Change
-60.36%
Ranking
Category
Stock Price
$14.40
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $774.85M, an increase of 508.68%. That is a compound annual growth rate of 16.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 774.80M | -60.27% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 780.56M |
| AbCellera Biologics | 779.77M |
| Cronos Group | 774.25M |
| Relay Therapeutics | 771.64M |
| Avanos Medical | 757.48M |
| Replimune Group | 754.64M |
| Erasca | 750.64M |
| Pliant Therapeutics | 749.72M |